Advertisement
Singapore markets closed
  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     
  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • Bitcoin USD

    64,185.14
    +632.90 (+1.00%)
     
  • CMC Crypto 200

    1,375.88
    +63.26 (+4.82%)
     
  • S&P 500

    4,987.39
    -23.73 (-0.47%)
     
  • Dow

    37,998.29
    +222.91 (+0.59%)
     
  • Nasdaq

    15,390.16
    -211.34 (-1.35%)
     
  • Gold

    2,414.40
    +16.40 (+0.68%)
     
  • Crude Oil

    83.50
    +0.77 (+0.93%)
     
  • 10-Yr Bond

    4.6190
    -0.0280 (-0.60%)
     
  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     
  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     
  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Spinraza Continues to See Improvement in Sales Metrics in 2017

Biogen (BIIB) and Ionis Pharmaceuticals’ (IONS) Spinraza has been witnessing improvement in infrastructure and payer access for spinal muscular atrophy (or SMA) patients in the US in 2017.